February 21, 2016
1 min read
Save

Oncologist joins Roswell Park Cancer Institute, University at Buffalo

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Marc S. Ernstoff, MD, has been appointed professor and chief of the division of hematology/oncology at Jacobs School of Medicine and Biomedical Sciences at University at Buffalo.

Ernstoff also will serve as chair of the division of hematology/oncology at UBMD Internal Medicine, as well as chair of the department of medicine and senior vice president of clinical investigation at Roswell Park Cancer Institute.

The appointments will take effect April 1.

“I’ve known Dr. Ernstoff as a colleague and collaborator, and I admire him tremendously. He’s one of the most inspiring leaders I know in oncology, and his accomplishments in every arena — clinical, academic and research — represent the best work being done today in our field,” Candace Johnson, PhD, president and CEO of Roswell Park Cancer Institute, said in a press release. “He is going to do great things for cancer patients, locally and far away from Western New York.”

Ernstoff’s clinical research focuses on the treatment of melanoma and genitourinary cancers. In 2014, Ernstoff became director of the melanoma program at Cleveland Clinic’s Taussig Cancer Institute.

He previously spent 13 years at Dartmouth College’s Geisel School of Medicine and Dartmouth-Hitchcock Medical Center. For most of his tenure there, he served as director of the melanoma program at Norris Cotton Cancer Center and as section chief of hematology/oncology. He also held positions at University of Pittsburgh’s School of Medicine and at Yale University.